Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Jennifer Dearborn"'
Publikováno v:
Cerebrovascular Diseases Extra, Vol 12, Iss 1, Pp 1-6 (2021)
Background: Obesity is associated with an increased prevalence of vascular risk factors and incidence of stroke. As such weight loss is recommended for patients living with obesity in the secondary prevention of stroke. Few studies, however, have exa
Externí odkaz:
https://doaj.org/article/d627c1b564a54eaab6e14ff8f34db28a
Autor:
Victor C Urrutia, Roland Faigle, Steven R Zeiler, Elisabeth B Marsh, Mona Bahouth, Mario Cerdan Trevino, Jennifer Dearborn, Richard Leigh, Susan Rice, Karen Lane, Mustapha Saheed, Peter Hill, Rafael H Llinas
Publikováno v:
PLoS ONE, Vol 13, Iss 5, p e0197714 (2018)
BACKGROUND:Up to 25% of acute stroke patients first note symptoms upon awakening. We hypothesized that patients awaking with stroke symptoms may be safely treated with intravenous alteplase (IV tPA) using non-contrast head CT (NCHCT), if they meet al
Externí odkaz:
https://doaj.org/article/871dc3f16c2e41f3915a3cfedf094a74
Autor:
Alvin Das, Elizabeth Heistand, Robert Regenhardt, Corey Fehnel, Jennifer Dearborn-Tomazos, Vasileios-Arsenios Lioutas, Sandeep Kumar, Magdy Selim
Publikováno v:
Monday, April 24.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0b58d331e46809c9f5611847d98f7816
https://doi.org/10.1212/wnl.0000000000204205
https://doi.org/10.1212/wnl.0000000000204205
Publikováno v:
Monday, April 24.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::148c3832c488b380b800617ad561c97a
https://doi.org/10.1212/wnl.0000000000201979
https://doi.org/10.1212/wnl.0000000000201979
Autor:
Gary A. Ford, J. D. Spence, Karen L. Furie, Walter N. Kernan, Silvio E. Inzucchi, Jennifer Dearborn-Tomazos, Catherine M. Viscoli, Anne M. Lovejoy, Lawrence H. Young, Mark Gorman
Publikováno v:
Department of Medicine Publications
Importance In the Insulin Resistance Intervention After Stroke (IRIS) randomized clinical trial, pioglitazone, an insulin-sensitizing agent, reduced the risk for recurrent stroke or myocardial infarction (MI) among patients with insulin resistance. H
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c98166e54c4e9b1607d8b8a5f5b8ff4b
https://ir.lib.uwo.ca/context/medpub/article/1192/viewcontent/Pioglitazone_20Therapy_20in_20Patients_20with_20Stroke_20and_20Prediabetes_20A_20Post_20Hoc_20Analysis_20of_20the_20IRIS_20Randomized_20Clinical_20Trial.pdf
https://ir.lib.uwo.ca/context/medpub/article/1192/viewcontent/Pioglitazone_20Therapy_20in_20Patients_20with_20Stroke_20and_20Prediabetes_20A_20Post_20Hoc_20Analysis_20of_20the_20IRIS_20Randomized_20Clinical_20Trial.pdf
Autor:
Lawrence Young, Silvio E. Inzucchi, Mark Gorman, Gary A. Ford, Catherine M. Viscoli, Anne M. Lovejoy, J. David Spence, Jennifer Dearborn-Tomazos, Karen L. Furie, Walter N. Kernan
Publikováno v:
Stroke. 50
Pioglitazone reduces insulin resistance and cardiovascular risk among patients with type 2 diabetes. The Insulin Resistance Intervention after Stroke (IRIS) trial randomized 3876 non-diabetic participants with recent stroke/TIA and insulin resistance
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1be4678cb44f329b0a528af189427cfa
https://doi.org/10.1161/str.50.suppl_1.tmp92
https://doi.org/10.1161/str.50.suppl_1.tmp92
Autor:
Daniel Zelterman, Lauren H Sansing, Jennifer Dearborn-Tomazos, Raisa Balbuena-Merle, Susanna A Curtis, Lesley Devine, Jeanne E. Hendrickson, John D. Roberts
Publikováno v:
Blood. 132:1093-1093
Background: Ischemic stroke is a cause of morbidity and mortality in children and adults with sickle cell disease (SCD). Recent studies showed that non-classical monocytes may be protective against vaso-occlusive crisis. Monocyte subsets have been ex
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ac52c80136de179da051581b3165cb4c
https://doi.org/10.1182/blood-2018-99-117504
https://doi.org/10.1182/blood-2018-99-117504